{'fraction_non_alphanumeric': 0.0198744769874477, 'fraction_numerical': 0.007322175732217573, 'mean_word_length': 4.662721893491124, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[Post-traumatic headache in outpatient therapy].

The author reports results achieved by a benzamide, tiapride, in the treatment of 43 subjects showing post-traumatic headaches in a INAIL out patient department of neurology. The drug was administered per os at a dose of one tablet twice a day at the beginning of the treatment. In 9 cases, the posology was afterwards increased to 3 tablets. Results were good in 72,1% of the cases and the positive action of the drug was not limited to the disappearance of the headache, but was extended to the total symptomatology of the subjective syndrome of the patients suffering from cranium trauma. The drug was well tolerated in all the cases except in one: the treatment had to be interrupted on account of vertigo sensations. The author confirms the possible activity of the molecule in posttraumatic headaches. He also points out the facility that it offers for the social and working recovery of the subject.